Li Y - Search Results

1

Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway.

Hou X, Du H, Quan X, Shi L, Zhang Q, Wu Y, Liu Y, Xiao J, Li Y, Lu L, Ai X, Zhan M, Yuan S, Sun L. Hou X, et al. Among authors: li y. Front Pharmacol. 2018 Feb 8;9:21. doi: 10.3389/fphar.2018.00021. eCollection 2018. Front Pharmacol. 2018. PMID: 29472856 Free PMC article.

2

[Research of high frequency induced thermotherapy efficiency for treatment of hepatocellular carcinoma].

Lu LG, Hu BS, Li Y, Luo PF, Chen XM. Lu LG, et al. Among authors: li y. Zhonghua Yi Xue Za Zhi. 2008 Jun 17;88(23):1618-20. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19035101 Clinical Trial. Chinese.

3

[Relationship between sorafenib-associated hand-food skin reaction and efficacy in treatment of advanced hepatocellular carcinoma].

Luo XN, Lu LG, Shao PJ, Hu BS, Li Y, Yu XY, He X. Luo XN, et al. Among authors: li y. Zhonghua Yi Xue Za Zhi. 2012 Apr 3;92(13):889-93. Zhonghua Yi Xue Za Zhi. 2012. PMID: 22781529 Chinese.

4

[Prognostic significance of serum level of vascular endothelial growth factor receptor-2 in hepatocellular carcinoma patients after transcatheter arterial chemoembolization].

Meng QW, Li Y, Hu BS, Shao PJ, Zhan MX, Yu XY, Lu LG. Meng QW, et al. Among authors: li y. Zhonghua Yi Xue Za Zhi. 2013 Jan 29;93(5):341-4. Zhonghua Yi Xue Za Zhi. 2013. PMID: 23660204 Chinese.

5

[Expression of serum microRNAs (miR-222, miR-181, miR-216) in human hepatocellular carcinoma and its clinical significance].

Zhan MX, Li Y, Hu BS, Shao PJ, Meng QW, He X, Huang JW, Lu LG. Zhan MX, et al. Among authors: li y. Zhonghua Yi Xue Za Zhi. 2013 Jun 18;93(23):1830-2. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24124720 Chinese.

6

Effects of sorafenib combined with chemoembolization and radiofrequency ablation for large, unresectable hepatocellular carcinomas.

Liang HY, Lu LG, Hu BS, Li Y, Shao PJ. Liang HY, et al. Among authors: li y. Chin Med J (Engl). 2013 Nov;126(22):4270-6. Chin Med J (Engl). 2013. PMID: 24238511

7

[Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].

Zhao Y, Li Y, Hu B, He X, Huang J, Zhan M, Lu L. Zhao Y, et al. Among authors: li y. Zhonghua Yi Xue Za Zhi. 2014 Feb 11;94(5):390-2. Zhonghua Yi Xue Za Zhi. 2014. PMID: 24746091 Chinese.

8

Serum microRNA-210 as a predictive biomarker for treatment response and prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Zhan M, Li Y, Hu B, He X, Huang J, Zhao Y, Fu S, Lu L. Zhan M, et al. Among authors: li y. J Vasc Interv Radiol. 2014 Aug;25(8):1279-1287.e1. doi: 10.1016/j.jvir.2014.04.013. Epub 2014 Jun 13. J Vasc Interv Radiol. 2014. PMID: 24935355

9

Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma.

Zheng YB, Huang JW, Zhan MX, Zhao W, Liu B, He X, Li Y, Hu BS, Lu LG. Zheng YB, et al. Among authors: li y. Tumour Biol. 2014 Nov;35(11):11473-81. doi: 10.1007/s13277-014-2478-8. Epub 2014 Aug 16. Tumour Biol. 2014. PMID: 25123269

10

The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib.

Zheng YB, Zhan MX, Zhao W, Liu B, Huang JW, He X, Fu SR, Zhao Y, Li Y, Hu BS, Lu LG. Zheng YB, et al. Among authors: li y. Med Oncol. 2014 Oct;31(10):209. doi: 10.1007/s12032-014-0209-z. Epub 2014 Sep 3. Med Oncol. 2014. PMID: 25182707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238,409 results

Search Page

Filters